The entire staff is friendly, supportive, and encouraging
Behringer, V., Deschner, T., Mstl, E., Selzer, D
Our experience reviewing preclinical data shows that credible ipamorelin research specifies administration route, confirms serum GH elevation post-dose, and measures downstream biomarkers (IGF-1, osteocalcin, hydroxyproline) to verify mechanism
GLP-1s may not be suitable for people who: Have a history of pancreatitis Have certain thyroid conditions (e.g., medullary thyroid cancer) Are pregnant or breastfeeding (depending on the specific medication) Have severe gastrointestinal conditions, like gastroparesis GLP-1 receptor agonists, including Tirzepatide, have been shown to lead to significant weight loss, with many people losing 10-15% of their body weight over time
doi: 10.1038/s41420-023-01606-8 35 MarquardtRKimTYooJTeasleyHFazleabasAYoungSet al